Get 20% lifetime commission for referring investors to digrin.com
here.
Matinas BioPharma Holdings, Inc. ( MTNB) - Key Metrics
MTNB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.21 | -$0.29 | -$0.29 |
| 2026Q1 | $0 | -$0.30 | -$0.25 | -$0.25 |
| 2025Q4 | $0 | -$0.35 | -$0.28 | -$0.28 |
| 2025Q3 | $0 | -$0.40 | -$0.27 | -$0.27 |
| 2025Q2 | $0 | -$1.03 | -$0.40 | -$0.40 |
MTNB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.73 |
| 2026Q1 | 0% | -0.42 |
| 2025Q4 | 0% | -0.49 |
| 2025Q3 | 0% | -1.18 |
| 2025Q2 | 0% | -0.22 |
MTNB
Price: $2.37
52 week price:
Earnings Per Share: -1.15 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 237100
Market Capitalization: 1.2 million